Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies is a research paper published in Cell Death Discovery (2024). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Commission
Grant: 101098001
Automated, miniaturized and accelerated drug discovery: AMADEUS
European Commission
Grant: 101087318
ERA Chair for Accelerated Synthetic Chemistry Technologies at Palacký University Olomouc
European Commission
Grant: 872195
Visualizing Death Inducing Protein Complexes
FWCI
3.89
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals